Objective-Low serum total cholesterol levels are associated with an increased risk of symptomatic intracerebral hemorrhage and with presence of asymptomatic cerebral microbleeds. The relative contribution of lipid fractions to these associations is unclear and requires investigation. We determined whether serum HDL-cholesterol, LDL-cholesterol, and triglycerides are associated with risk of intracerebral hemorrhage and presence of cerebral microbleeds. Methods and Results-Nine thousand sixty-eight stroke-free community-dwelling persons aged Ն55 were followed from baseline of whom 85 suffered from intracerebral hemorrhage during follow-up.
I ntracerebral hemorrhage accounts for about 10% to 15% of strokes and is a devastating disease for which there are currently no curative treatment options. 1, 2 Therefore, identification of modifiable risk factors is highly important. Low levels of serum total cholesterol have long been recognized as a possible risk factor for intracerebral hemorrhage. 3 The exact role of cholesterol in the pathogenesis of intracerebral hemorrhage is unclear, although some studies suggest that low cholesterol levels make the cerebrovascular endothelium fragile and vulnerable for leakage and rupture. 4 -6 Low total cholesterol levels also relate to the presence of cerebral microbleeds, 7, 8 which are thought to be asymptomatic precursors of symptomatic intracerebral hemorrhage. 9, 10 Establishing overlap in risk factors for intracerebral hemorrhage and cerebral microbleeds may thus aid in the early detection of persons at an increased risk of intracerebral hemorrhage.
Although various cohort studies show that serum total cholesterol levels are inversely related with intracerebral hemorrhage, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] it is unclear how various serum lipid fractions associate with intracerebral hemorrhage. Studies investigating lipid fractions, ie, LDL-cholesterol, HDL-cholesterol, and tri-glycerides, have reported inconsistent results. [13] [14] [15] [16] [17] 19, [23] [24] [25] However, recent evidence suggests that the association between total cholesterol levels and risk of intracerebral hemorrhage is mainly driven by low triglyceride levels. 19, 23 Still, further confirmation of these results is needed. Moreover, it is unclear whether similar patterns of lipid fractions also underlie the association of cholesterol with cerebral microbleeds. Therefore, we investigated in a large population-based cohort of community-dwelling elderly people whether serum total cholesterol and in particular the levels of LDL-cholesterol, HDL-cholesterol, and triglycerides are associated with the risk of intracerebral hemorrhage. Because we also aimed to investigate the potential of these lipid fractions as risk factors for preclinical disease, we studied the associations between lipid fractions and the presence of cerebral microbleeds.
that are frequent in the elderly. The rationale and design of the study have been described extensively elsewhere. 26 Briefly, the cohort started in 1990 and included 7983 participants who were aged Ն55 years and living in Ommoord, a district in Rotterdam in the Netherlands (Rotterdam Study I). In 2000, the cohort was expanded with 3011 participants who had reached the age of 55 or had moved into the district since the start of the study (Rotterdam Study II). All participants underwent a comprehensive set of baseline examinations which were repeated during regular follow-up visits, approximately every 3 to 5 years. In 2005, a random subset of Rotterdam Study II underwent brain MRI. The study was approved by the Medical Ethics Committee of the Erasmus University Medical Center and all participants gave written informed consent to participate in the study.
Measurement of Serum Lipid Levels
Venous blood samples were obtained from all participants at each visit ( Figure) . In 1990, nonfasting serum total cholesterol and HDL-cholesterol levels were measured, using enzymatic colorimetric methods (Kone Specific Analyzer, Kone Instruments). From 1997 onwards, fasting total cholesterol and HDL-cholesterol as well as fasting triglyceride levels were determined using comparable enzymatic procedures (Hitachi Analyzer, Roche Diagnostics). Lipid measurements were carried out at the Erasmus Medical Center in 2 laboratories (Department of Epidemiology laboratory and Clinical Chemistry laboratory), which both participated in the Dutch National Cholesterol Standardization Program, analogous to the Center for Disease Control and Prevention quality assurance and standardization programs (Atlanta, GA). All measurements fulfilled the WHO criteria for precision and accuracy of lipid measurements. Non-HDL-cholesterol) was calculated by subtracting HDL-cholesterol from total cholesterol. The Friedewald equation was used to estimate LDL-cholesterol. 27 Pearson's correlation coefficients for the various lipid fractions were weak to modest: HDL-cholesterol and triglycerides, rϭ0.50; HDL-cholesterol and LDL-cholesterol, rϭϪ0.07; and LDL-cholesterol and triglycerides, rϭ0.20. Triglyceride levels were natural log-transformed because their distribution was severely skewed to the right.
Population for Analysis
Because in different examination visits either nonfasting or fasting blood samples were drawn, we performed our analyses based on the following 3 combined sets of participants. This was done in order to obtain the largest numbers of intracerebral hemorrhage (Figure) : Of the total of 10,994 Rotterdam Study participants, we excluded persons who had had a stroke before their first examination (nϭ363), participants who had not given consent for the collection of follow-up data from general practitioners (nϭ195), participants who had not visited the research center for blood sampling due to death, refusal or physical inability (nϭ929), and participants of whom blood draw or storage had failed (nϭ412). Because the Friedewald equation is not valid if triglyceride levels exceed 4.52 mmol/L (400 mg/dL), 27 we further excluded participants with triglyceride levels above this value (nϭ31). This resulted in a total of 9068 participants for Set 1 (Rotterdam Study I, nϭ6753; Rotterdam Study II, nϭ2315). Of the 4797 persons who took part in the third examination of Rotterdam Study I, we excluded 243 participants who had a prevalent stroke at that examination, 5 participants who had not given informed consent for the collection of follow-up data, 1072 participants of whom lipid levels were not available, and 24 participants with triglyceride levels Ͼ4.52 mmol/L. Combining these 3458 persons with 2315 from Rotterdam Study II resulted in 5773 participants in Set 2. Set 3 comprised a random subset of Rotterdam Study II participants who underwent brain MRI and of whom we had lipid measurements available (nϭ789).
Assessment of Stroke
Stroke was defined according to WHO criteria as a syndrome of rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to death, with no apparent cause other than of vascular origin. 28 History of stroke at baseline was assessed during the baseline interview and verified by reviewing medical records. After enrollment, participants were continuously monitored for incident stroke through automated linkage of the study database with files from general practitioners. Nursing home physicians' files and files from general practitioners of participants who moved out of the district were checked on a regular basis as well. Additional information was obtained from hospital records. Potential strokes were reviewed by research physicians, and verified by an experienced stroke neurologist (P.J.K.). Strokes were further classified as cerebral infarction or intracerebral hemorrhage on the basis of neuroimaging reports. If neuroimaging was lacking, a stroke was classified as unspecified. Subarachnoid hemorrhages due to ruptured aneurysms were not considered stroke events.
Participants were followed from study entry to stroke, death, last health status update when they were known to be stroke-free, or January 1, 2009, whichever came first. Follow-up was complete up to January 1, 2009 for 98.4% of potential person years.
Brain MRI and Rating of Cerebral Microbleeds
A multisequence MRI protocol was carried out on a 1.5-T scanner (GE Healthcare, Milwaukee, WI). 7 A custom-made accelerated 3-dimensional T2*-weighted gradient-recalled echo (3D T2* GRE) sequence with high spatial resolution and long echo time was used for microbleed detection. 29 All 3D T2* GRE scans were reviewed by 1 of 2 trained raters who recorded the presence, number, and location of cerebral microbleeds. 7 Cerebral microbleeds were categorized into 1 of 3 locations: lobar (cortical gray and subcortical or periventricular white matter), deep (deep gray matter: basal ganglia and thalamus, and the white matter of the corpus callosum, internal, external, and extreme capsule), and infratentorial (brain stem and cerebellum). 7
Other Measurements
Trained research physicians visited all participants at home for standardized questionnaires about their health status and medical history, including questions about current medication use, cigarette smoking behavior and average amount of alcohol intake. 30 Subsequently, all participants visited the research center twice for physical examination and blood sampling. Blood pressure was calculated as the average of 2 measurements at the right brachial artery with a random-zero sphygmomanometer after 5 minutes of rest while the subject was in a sitting position. Hypertension was defined as a diastolic blood pressure of Ն90 mm Hg and/or a systolic blood pressure of Ն140 mm Hg, and/or the use of blood pressure-lowering medication. 31 Diabetes mellitus was defined as a fasting serum glucose level Ն7.0 mmol/L, a nonfasting or postload serum glucose level Ն11.1 mmol/L and/or the use of blood glucose-lowering drugs. Fasting serum insulin level was determined by metric assay (Biosource Diagnostics, Camarillo, CA). 32 Body mass index was calcu-lated as weight (in kilograms) divided by the square of height (in meters).
Statistical Analysis
Cox regression was used to calculate hazard ratios and 95% confidence intervals for the associations between lipid levels and risk of intracerebral hemorrhage, expressed per standard deviation increase in serum lipid level. Associations between total cholesterol, HDL-cholesterol and non-HDL-cholesterol, and intracerebral hemorrhage were calculated in Set 1 (Figure) ; associations between LDL-cholesterol and triglycerides, and intracerebral hemorrhage were calculated in Set 2 (Figure) . For both sets, we constructed 2 models. In model 1 we adjusted for age, sex, lipid-lowering medication use (yes/no), and Rotterdam Study subcohort (RS-I/RS-II). In model 2, we adjusted for age, sex, and a propensity score that included the following potential confounders: lipid-lowering medication use, systolic blood pressure (continuous), blood pressurelowering medication use (yes/no), diabetes mellitus (yes/no), serum glucose level (continuous), current cigarette smoking (yes/no), body mass index (continuous), antithrombotic medication use (yes/no), alcohol intake (continuous), and subcohort. We adjusted for a propensity score instead of individual confounders because the number of intracerebral hemorrhages was small compared to the large number of potential confounders. 33, 34 Statin treatment might modify the association between lipid levels and intracerebral hemorrhage. 35 Therefore, we investigated whether the associations between lipid levels and intracerebral hemorrhage differed across strata of lipid-lowering medication use and we tested the presence of interaction. These analyses were performed in Set 2. Hazard ratios were expressed per standard deviation increase in lipid level and were adjusted for age, sex, and a propensity score of potential confounders (systolic blood pressure, blood pressurelowering medication use, diabetes mellitus, serum glucose level, serum insulin level, current cigarette smoking, body mass index, antithrombotic medication use, alcohol intake, and subcohort).
Subsequently, we investigated whether the associations between HDL-cholesterol, LDL-cholesterol, triglycerides, and risk of intracerebral hemorrhage were independent of each other, by entering these lipid fractions simultaneously in the Cox regression models. The analyses were performed in Set 2. We adjusted for age, sex, a propensity score of potential confounders (lipid-lowering medication use, systolic blood pressure, blood pressure-lowering medication use, diabetes mellitus, serum glucose level, serum insulin level, current cigarette smoking, body mass index, antithrombotic medication use, alcohol intake, and subcohort) and for the other lipid fractions. To verify the log-linearity of associations, we also categorized lipid levels in quartiles using the lowest quartile as the reference category.
Finally, we determined the associations between HDL-cholesterol, LDL-cholesterol, and triglycerides, and the presence of deep or infratentorial (with or without lobar microbleeds) versus strictly lobar cerebral microbleeds, using logistic regression models. These analyses were carried out in Set 3. Associations were adjusted for age, sex, a propensity score (lipid-lowering medication use, systolic blood pressure, blood pressure-lowering medication use, diabetes mellitus, serum glucose level, serum insulin level, current cigarette smoking, body mass index, antithrombotic medication use, and alcohol intake), and the complementary lipid fractions. Odds ratios were expressed per standard deviation increase and in quartile categories.
In each set, covariate adjustments were based on data that were collected during the same visit as the blood sample in which the lipid levels were determined. We did not have complete data on all covariates. Alcohol intake was missing in 15.4%; other covariates were missing in less than 4% of participants. Missing values in covariates were imputed with a linear regression model based on age and sex. All analyses were performed using SPSS for Windows, version 16.0 (SPSS Inc., Chicago, IL).
Results
During 97,956 person years of follow-up (median 9.7 years), 1005 participants developed a first-ever stroke, which was classified in 85 as intracerebral hemorrhage, in 561 as cerebral infarction, and in 359 as unspecified. Of the 85 intracerebral hemorrhages, 73 had occurred in Rotterdam Study I (33 after the start of the third visit), and 12 in Rotterdam Study II. Cerebral microbleeds were present in 162 (20.5%) of the 789 participants who underwent brain MRI; microbleeds were localized in deep or infratentorial brain regions in 65 participants and were strictly lobar in location in 97. Baseline characteristics of the Rotterdam Study population are shown in the Figure and in Table 1 . Alcohol intake and antithrombotic medication use were higher in 1997 and 2000 than in 1990, whereas median total cholesterol and non-HDL-cholesterol levels were much higher in 1990 than in 1997 and 2000. Lipid-lowering medication use was more common 1997 and 2000 than in 1990 (13.1% and 12.0% versus 2.4%). Table 2 shows the associations between serum lipid levels and risk of intracerebral hemorrhage. As expected, decreasing levels of total serum cholesterol were associated with an increasing risk of intracerebral hemorrhage. This was particularly due to an inverse association between the non-HDL-cholesterol fraction and intracerebral hemorrhage. LDL-cholesterol was not associated with risk of intracerebral hemorrhage. Triglyceride levels showed a strong inverse association with risk of intracerebral hemorrhage, independently of age, sex, lipid-lowering medication use, and multiple potential confounders. Analyses based on Set 1 or Set 2 (Figure) . Hazard ratios are expressed per SD increase in lipid level. *Triglyceride levels are natural log-transformed. Model I: Adjusted for age, sex, lipid-lowering medication use and subcohort. Model II: Adjusted for age, sex, and a propensity score of potential confounders (lipid-lowering medication use, systolic blood pressure, blood pressure-lowering medication use, diabetes mellitus, serum glucose level, current cigarette smoking, body mass index, antithrombotic medication use, alcohol intake and subcohort). Note: HRs from Set 1 and Set 2 are not directly comparable because of different datasets and log-transformation of triglycerides.
Stratification by lipid-lowering medication use did not reveal differences across strata, although numbers were small. Consequently, probability values for interaction were all nonsignificant (Table 3) .
In Table 4 we present the independent effects of each of the lipid fractions on risk of intracerebral hemorrhage. The borderline association between HDL-cholesterol and intracerebral hemorrhage was strongly attenuated after adjustment for triglyceride levels. In contrast, the strong association between increasing triglyceride levels and decreasing risk of intracerebral hemorrhage was not affected by adjustments for HDL-cholesterol or LDL-cholesterol levels.
Associations between HDL-cholesterol, LDL-cholesterol, triglycerides, and presence of cerebral microbleeds are shown in Table 5 . Serum triglyceride levels were strongly and inversely associated with the presence of deep or infratentorial microbleeds, but not with strictly lobar microbleeds. There was also a trend toward an inverse relationship between HDL-cholesterol and LDL-cholesterol and presence of deep or infratentorial microbleeds, but these associations were far from significant.
Discussion
In this prospective population-based cohort study among people aged 55 years or older who were free from stroke at baseline, we confirmed that serum total cholesterol levels were inversely associated with the risk of intracerebral hemorrhage. When investigating the various lipid fractions, we found that the association was due to a strong inverse relationship between triglyceride levels and risk of intracerebral hemorrhage, and not due to HDL-cholesterol or LDL- Analyses are based on Set 2 (Figure) . Hazard ratios are expressed per SD increase in lipid level and are adjusted for age, sex, and a propensity score of potential confounders (systolic blood pressure, blood pressure-lowering medication use, diabetes mellitus, serum glucose level, serum insulin level, current cigarette smoking, body mass index, antithrombotic medication use, alcohol intake and subcohort). *Triglyceride levels are natural log-transformed. Analyses based on Set 2 (Figure) . *Triglyceride levels are natural log-transformed. Basic model: adjusted for age, sex, and a propensity score of potential confounders (lipid-lowering medication use, systolic blood pressure, blood pressure-lowering medication use, diabetes mellitus, serum glucose level, serum insulin level, current cigarette smoking, body mass index, antithrombotic medication use, alcohol intake and subcohort). HDL-C indicates HDL-cholesterol; LDL-C, LDL-cholesterol; TG, triglycerides. cholesterol levels. Similarly, we found an inverse association between triglyceride levels and the presence of cerebral microbleeds in the deep or infratentorial brain regions.
Strengths of this study include the prospective and population-based design, the large number of participants, and the long duration and completeness of follow-up. Furthermore, we were able to study lipid levels in association with both asymptomatic microbleeds and symptomatic intracerebral hemorrhage. However, the study also has limitations. We did not include 1368 participants in the analysis because of incomplete data on lipid levels. These participants were older (median age 73 versus 66 years), more often female (66% versus 59%), and more likely to have cardiovascular risk factors. It is possible that exclusion of these participants introduced a selection bias that could have affected the estimates. Loss to follow-up, another potential source of selection bias, was only 1.6%. Another issue is that 36% of strokes were classified as "unspecified" because neuroimaging had not been performed, which is similar to unspecified stroke rates reported in other population-based or even hospital-based studies. 36, 37 Therefore it is likely that an unknown number of intracerebral hemorrhages were misclassified as unspecified. Apart from conventional stroke risk factors, major determinants of unspecified stroke risk are older age, living in a nursing home and dementia prior to stroke. Although this misclassification was independent of exposure measurement and therefore nondifferential, it may have resulted in an underestimation of the true associations between lipid levels and intracerebral hemorrhage. However, because we observed very similar patterns between lipid levels and cerebral microbleeds, we think that misclassification, if any, has not importantly influenced our results. In addition, differences were observed in cholesterol levels, use of lipid-lowering medication, and some other covariates between the sets of 1990, 1997, and 2000. These differences are likely to be explained by time-effects between successive follow-up visits. Given that we adjusted for these variables in the analyses, these differences probably did not have a strong impact on the results. MRI scans were carried out approximately 5 years after blood samples were drawn. However, previous studies have shown that, once present, cerebral microbleeds rarely disappear. 38 We found that low triglyceride levels are associated with an increased risk of intracerebral hemorrhage, independently of lipid-lowering medication use, levels of LDL-cholesterol and HDL-cholesterol, and other potential confounders. This finding is in agreement with results from the Three-City Study, which reported a similar inverse association between low triglyceride levels and intracerebral hemorrhage, 23 and with results from a pooled cohort study among Atherosclerosis Risk in Communities Study participants and Cardiovascular Health Study participants. 19 However, three other studies did not detect an association between triglyceride levels and intracerebral hemorrhage. 14 -16 Analyses of the Copenhagen Heart Study and Oslo Study were based on nonfasting triglyceride levels and included only few events. 14 -15 Further- Analyses based on Set 3 (Figure) . *Triglyceride levels are natural log transformed. †With or without lobar microbleeds. ‡Presence of strictly lobar microbleeds vs absence of microbleeds. §Presence of deep or infratentorial microbleeds vs absence of microbleeds. Odds ratios are adjusted for age, sex, a propensity score (lipid-lowering medication use, systolic blood pressure, blood pressure-lowering medication use, diabetes mellitus, serum glucose level, serum insulin level, current cigarette smoking, body mass index, antithrombotic medication use, and alcohol intake), and HDL-cholesterol, LDL-cholesterol and triglyceride levels when applicable.
more, results of the Oslo Study were based on 21 years of follow-up, which may have diluted the effect. 15 The lack of an association observed by the Japan Lipid Intervention Trial could be due to the fact that they only included hypercholesterolemic patients with relatively high triglyceride levels. 16 Although the mechanism of the association between triglyceride levels and intracerebral hemorrhage is unknown, there are some possible explanations. Several studies have suggested that high triglyceride levels favor a prothrombotic state because they are positively correlated with the vitamin K-dependent coagulation factors VII and IX, and with plasminogen activator inhibitor and blood viscosity. 39 Likewise, one could hypothesize that low triglyceride levels may result in a prohemorrhagic state. Another possible explanation is that low triglyceride levels may contribute to weakness of the vascular endothelium. Cholesterol and fatty acids are essential elements of all cell membranes. In vitro studies have shown that low cholesterol levels result in increased permeability of erythrocyte membranes, 4 and animal studies reported that low cholesterol levels cause smooth muscle degeneration and endothelial weakness in small intracerebral arteries. 18 Therefore it has been hypothesized that very low cholesterol levels may contribute to the development of a fragile endothelium, prone to leakage and rupture. 5 However, whether any of these perspectives explain the observed association between low triglyceride levels and the risk of intracerebral hemorrhage remains uncertain and requires further investigation. We also cannot exclude the possibility of residual confounding by unmeasured determinants, for example diet or physical activity, or due to the fact that lipid levels and confounders were measured only once. Therefore, studies using time-varying analyses are needed to explore whether intraindividual fluctuations in lipid levels and confounders influence the results.
We further found a comparable inverse association between triglyceride levels and presence of cerebral microbleeds, which provides accumulating support for a parallel between asymptomatic microbleeds and symptomatic intracerebral hemorrhage. 40, 41 However, although not significant, associations of HDL-cholesterol and LDL-cholesterol with cerebral microbleeds seemed somewhat different from the associations with intracerebral hemorrhage. This may indicate that intracerebral hemorrhage and cerebral microbleeds are reflections of a different stage of arteriolosclerosis. Moreover, we cannot fully rule out the possibility that intracerebral hemorrhage and microbleeds do not completely share the same underlying pathology.
Our finding that triglycerides are related to deep or infratentorial microbleeds rather than lobar microbleeds may provide etiologic clues for the association between triglycerides and intracerebral hemorrhage. In a previous study, we showed that lobar microbleeds are indicative of underlying amyloid angiopathy, whereas deep or infratentorial microbleeds are associated with known risk factors for arteriolosclerosis. 42 The association between triglycerides and deep or infratentorial microbleeds but not lobar microbleeds underscores these differences in underlying pathology and is suggestive for a role of triglyceride levels through development of arteriolosclerotic microangiopathy.
To conclude, in this large population-based cohort study among elderly people we found that low serum triglyceride levels were associated both with an increased risk of intracerebral hemorrhage as well as with the presence of deep or infratentorial cerebral microbleeds. This finding provides novel insights into the role of lipid metabolism in the etiology of intracerebral hemorrhage. Though the exact mechanism of the association remains unclear, triglyceride levels may aid in the identification of people at risk for intracerebral hemorrhage.
